Liver MRI With Primovist/Eovist in Pediatric Subjects Who Are Suspected or Have Focal Liver Lesions.
Status:
Completed
Trial end date:
2013-04-01
Target enrollment:
Participant gender:
Summary
Medical records are reviewed to obtain information about the use of a MRI diagnostic imaging
agent (contrast agent) called Primovist/Eovist in children older than 2 months and less than
18 years. Data that has been recorded in the child's medical records relating to the
injection of Primovist/Eovist will be collected. Information will be collected from up to 2
weeks before the child received Primovist/Eovist until 12 months after the child received
Primovist/Eovist. Copy of the child's MR images that were taken right before and after the
child received Primovist/Eovist and all other reports (laboratory reports, other imaging
reports, etc) that are part of the child's medical records during that time period will be
collected.